| |
| |
|
| Insider
Information: |
Booth Andrew |
| Relationship: |
Chief Financial Officer |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
153,000 |
|
|
Indirect Shares
|
130,959 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
283,959 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abcellera Biologics Inc. |
ABCL |
Chief Financial Officer |
2023-05-26 |
153,000 |
2023-05-26 |
130,959 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2023-05-26 |
4 |
B |
$6.85 |
$99,325 |
D/D |
14,500 |
153,000 |
2.74 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2022-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
138,500 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2022-12-20 |
4 |
OE |
$0.19 |
$9,500 |
D/D |
50,000 |
188,500 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2022-05-12 |
4 |
B |
$5.79 |
$492,150 |
D/D |
85,000 |
138,500 |
2.74 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2021-12-10 |
4 |
OE |
$0.32 |
$160,000 |
D/D |
500,000 |
553,500 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2021-11-11 |
4 |
B |
$14.61 |
$204,540 |
I/I |
14,000 |
130,959 |
1.99 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2021-11-11 |
4 |
B |
$14.74 |
$788,590 |
D/D |
53,500 |
53,500 |
2.74 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2021-06-09 |
4 |
S |
$25.50 |
$30,600,000 |
D/D |
(1,200,000) |
0 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial Officer |
• – – |
2021-06-07 |
4 |
OE |
$0.19 |
$306,000 |
D/D |
1,200,000 |
1,200,000 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
116,959 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
